Manufacturing & Lab Equipment
Company Overview
About
Omerin is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2007
Employees:2,507
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval 14PO1T
PMDA · #APR-K20VN1O1 · 2021-10-01
Drug Approval UHUSRU
FDA · #APR-QEFNJYBF · 2022-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-GG0JZ50F
Issued: 2020-10-26
Expires: 2025-02-05
Health Canada GMP
Health Canada
Cert #: CERT-SJ2MS7O5
Issued: 2020-08-25
Expires: 2025-11-11
Loading CDMO intelligence...
Key facts about Omerin
- Omerin is headquartered in France.
- Omerin was founded in 2007.
- Omerin has 2,507 employees.
- Omerin's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Omerin
Directory pages this company appears in, each with the full list of matching manufacturers.